This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Loscalzo J (2006) Homocysteine trials—clear outcomes for complex reasons. N Engl J Med 354: 1629–1632
Ducloux D et al. (2006) Impact of malnutrition–inflammation on the association between homocysteine and mortality. Kidney Int 69: 331–335
Ingrosso D et al. (2003) Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361: 1693–1699
Jacobsen DW (2006) Homocysteine targeting of plasma proteins in hemodialysis patients. Kidney Int 69: 787–789
Andersson A et al. (1992) Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem 38: 1311–1315
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
De Santo, N., Perna, A. Do elevated homocysteine levels predict mortality in chronic kidney disease stages 3–4?. Nat Rev Nephrol 2, 614–615 (2006). https://doi.org/10.1038/ncpneph0314
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0314